securities fraud

ChowChow Cloud International faces class action lawsuit alleging executives concealed pump-and-dump scheme. Stock collapsed 84.3% in December 2025; lead plaintiff deadline set for May 2026.

Aldeyra Therapeutics faces securities fraud lawsuit alleging it concealed reproxalap trial data inconsistencies, leading to 70.7% stock collapse after FDA rejection in March 2026.

Coty Inc. faces securities fraud lawsuit alleging misleading growth guidance before 22% stock plunge. Law firm seeks class action damages.

Hercules Capital faces securities fraud suit alleging CEO and CFO certified misleading statements on valuations. Stock fell 7.9% after announcement; lead plaintiff deadline set for May 19, 2026.

Gossamer Bio faces securities fraud lawsuit after stock plummets 80% following disclosure of allegedly undisclosed Latin American trial site enrollment practices that compromised Phase 3 study results. Lead plaintiff deadline is June 1, 2026.

Class action lawsuit filed against $UHG alleges controlling shareholder concealed forced-sale plan, devalued company, and forced director resignations to harm minority shareholders.

Camping World Holdings faces securities fraud lawsuit alleging false inventory management and demand claims between April 2025 and February 2026, with lead plaintiffs being recruited.

Driven Brands ($DRVN) faces class action lawsuit alleging securities fraud through overstated revenue and cash, understated expenses for 2023-2024.

Schall Law Firm files class action against $NAVN for allegedly concealing post-IPO sales and marketing expenditure needs during October 2025 IPO.

Schall Law Firm initiates securities fraud class action against uniQure ($QURE) over alleged false FDA approval statements and misleading BLA timelines.

Robbins Geller files class action against $MEDP over alleged false book-to-bill projections. Stock fell 16% after Q4 miss. Lead plaintiff deadline: June 8, 2026.

Driven Brands faces class action lawsuit over accounting restatement for fiscal 2023-2024. Stock plummeted 40% after disclosure of lease, cash, and revenue errors.

The Schall Law Firm investigates $SMPL for alleged securities fraud following April 9 guidance cut forecasting up to 10% sales decline and significant EBITDA drop.

ImmunityBio faces securities fraud lawsuit after FDA warning over false Anktiva claims. Stock plunged 21%. Investor deadline May 26, 2026.

Law firm files class action lawsuit against Pinterest for allegedly making false statements about advertising revenues and tariff impacts. Stock dropped 16.8% after disappointing earnings.

Barclays faces class action investigation over £600M undisclosed exposure to collapsed UK mortgage lender, triggering stock declines and regulatory scrutiny.

America's Car-Mart ($CRMT) stock fell 18.2% after disappointing earnings. Securities lawyers are investigating alleged misleading disclosures and preparing class action lawsuits.

PennyMac Financial Services ($PFSI) stock crashed 33.3% following weak Q4 earnings, prompting securities litigation over allegedly misleading disclosures.

Kessler Topaz files class action against $PYPL for alleged false revenue guidance. Stock plunged 20.3% after CEO ouster and missed earnings February 3, 2026.

Gemini Space Station Inc. faces securities fraud lawsuit with May 18, 2026 deadline. Stock collapsed 78.7% from $28 IPO price to $5.96 following corporate pivot and leadership exodus.